Difference between revisions of "Team:Shanghai Metro/Contribution"

 
Line 42: Line 42:
 
                     <div class="sub-nav">
 
                     <div class="sub-nav">
 
                         <ul>
 
                         <ul>
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Collection" class="sub-nav-74">Parts
+
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Parts" class="sub-nav-74">Parts
 
                                     Collection</a></li>
 
                                     Collection</a></li>
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Engineering"
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Engineering"
Line 92: Line 92:
 
     <div class="sub-content">
 
     <div class="sub-content">
 
         <div class="sub-title">Parts Contribution</div>
 
         <div class="sub-title">Parts Contribution</div>
         <div class="article-title">==Contribution==</div>
+
         <div class="article-title">BBa_K4028000</div>
 +
        <div class="article-content"><b>== Profile ==</b></div>
 +
        <div class="article-content">
 +
            Name: tke2<br />
 +
            Base Pairs: 4158 bp<br />
 +
            Origin: Pseudomonas putida KT2440, genome<br />
 +
            Properties: Anti-bacterial effector in type VI secretion system
 +
        </div>
 +
        <div class="article-content"><b>== Usage and Biology ==</b></div>
 
         <div class="article-content">BBa_K4028000 is a coding sequence of tke2 from Pseudomonas putida KT2440. Tke2,
 
         <div class="article-content">BBa_K4028000 is a coding sequence of tke2 from Pseudomonas putida KT2440. Tke2,
             known as a toxic Rhs-type
+
             known as a toxic Rhs-type effector, is an effect factor in type VI secretion system (T6SS).
            effector, is an effect factor in type VI secretion system (T6SS).<br />
+
 
             A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic
 
             A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic
 
             pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut
 
             pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut
Line 105: Line 112:
 
         </div>
 
         </div>
 
         <div class="img-wrap">
 
         <div class="img-wrap">
             <img src="https://static.igem.org/mediawiki/2021/7/77/T--Shanghai_Metro--contribution01.png" alt="">
+
             <img src="https://static.igem.org/mediawiki/2021/0/01/T--Shanghai_Metro--contribution01.jpg" alt="">
 
             <span>Figure1. Principle diagram of T6SS.</span>
 
             <span>Figure1. Principle diagram of T6SS.</span>
 
         </div>
 
         </div>
         <div class="article-title">==Reference==</div>
+
         <div class="article-title">BBa_K4028001</div>
         <div class="article-content">1. Bingle, l.E.H. et al. (2008). Type VI secretion: a beginner’s guide. Current
+
         <div class="article-content"><b>== Profile ==</b></div>
            opinion in microbiology. 11:3-8.</div>
+
         <div class="article-content">
         <div class="article-content">2. Silverman, J. M. et al. (2012). Structure and regulation of the type VI
+
            Name: ike2<br />
            secretion system. 66:453-472.</div>
+
            Base Pairs: 447bp<br />
         <div class="article-content">3. Hernandez, R. E. et al. (2020). Type VI secretion system effector protein:
+
            Origin: Pseudomonas putida KT2440, genome<br />
            Effective weapons for bacterial competitiveness. Cellular microbiology. 22:e13241.</div>
+
            Properties: Immunity effector in type VI secretion system
         <div class="article-content">4. Hood RD, . et al (January 2010). "A type VI secretion system ofPseudomonas
+
        </div>
             aeruginosa targets a toxin to bacteria". Cell Host & Microbe. 7 (1): 25–37. doi:10.1016/j.chom.2009.12.007.
+
         <div class="article-content"><b>== Usage and Biology ==</b></div>
             PMC 2831478. PMID 20114026.</div>
+
         <div class="article-content">
         <div class="article-content">5. Russell AB, . et al (August 2014). "A type VI secretion-related pathway in
+
            BBa_K4028001 is a coding sequence of ike2, an immunity protein in Pseudomonas putida KT2440. Ike2 is used
            Bacteroidetes mediates interbacterial antagonism". Cell Host & Microbe. 16 (2): 227–236.
+
            for protecting bacteria from type VI secretion system (T6SS). <br />
            doi:10.1016/j.chom.2014.07.007. PMC 4136423. PMID 25070807.</div>
+
             A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic
         <div class="article-content">6. Ma LS, . et al (July 2014). "Agrobacterium tumefaciens deploys a superfamily of
+
            pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut
            type VI secretion DNase effectors as weapons for interbacterial competition in planta". Cell Host & Microbe.
+
            (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural
            16 (1): 94–104. doi:10.1016/j.chom.2014.06.002. PMC 4096383. PMID 24981331.</div>
+
            conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects
         <div class="article-content">This is the naturally occurring version of the TetR class B promoter. It can be
+
            (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting
             induced by tetracycline to express downstream proteins.</div>
+
            the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate and produce corresponding
         <div class="article-title">==Contribution==</div>
+
             immune protein (ike2) to counteract the damage caused by toxic effector factors.[1,2,3]
         <div class="article-content">We set different tetracycline concentrations to test the protein expression induced
+
        </div>
            by TetR(B) promoter. In our design, the immune protein (ike4) is regulated by TetR(B) promoter. The
+
         <div class="article-title">BBa_K4028005</div>
            expression of the immune protein (ike4) directly affects and is positively correlated with strain growth.
+
         <div class="article-content"><b>== Profile ==</b></div>
            Therefore, the strain growth can indicate the regulation of the TetR(B) promoter.</div>
+
         <div class="article-content">
        <div class="article-content">The results of the test are below.</div>
+
            Name: tet promoter<br />
 +
             Base Pairs: 56bp<br />
 +
            Origin: Escherichia coli, synthetic<br />
 +
            Properties: Inducible promoter regulated by tetracycline
 +
        </div>
 +
         <div class="article-content"><b>== Usage and Biology ==</b></div>
 +
         <div class="article-content">
 +
            This is the naturally-occuring version of the TetR class B promoter. Note that this will promote
 +
            bidirectionally. (pR1 and pR2 will promote in the forward direction; pA will promote in the reverse
 +
            direction.) The three transcription start sites are not labeled, but can be found from the reference. <br />
 +
            We set different tetracycline concentrations to test the protein expression induced by TetR(B) promoter. In
 +
            our design, the immune protein (ike4) is regulated by TetR(B) promoter. The expression of the immune protein
 +
            (ike4) directly affects and is positively correlated with strain growth. Therefore, the strain growth can
 +
            indicate the regulation of the TetR(B) promoter.<br />
 +
            The results of the test are below.
 +
        </div>
 
         <div class="img-wrap">
 
         <div class="img-wrap">
             <span>Table 1. OD<sub>600</sub> value of the strain D: Pus232-ike4-tke4 after 6 hours</span>
+
             <span>Table 1. OD600 value of the strain D: Pus232-ike4-tke4 after 6 hours</span>
             <img src="https://static.igem.org/mediawiki/2021/b/b2/T--Shanghai_Metro--contribution02.png" alt="">
+
             <img src="https://static.igem.org/mediawiki/2021/c/cd/T--Shanghai_Metro--contribution02.jpg" alt="">
 
         </div>
 
         </div>
 
         <div class="img-wrap">
 
         <div class="img-wrap">
             <img src="https://static.igem.org/mediawiki/2021/d/da/T--Shanghai_Metro--contribution03.png" alt="">
+
             <img src="https://static.igem.org/mediawiki/2021/2/27/T--Shanghai_Metro--contribution03.jpg" alt="">
 
             <span>Figure 1. Biomass Concentration curve of Pus323-tke4-ike4 Strain with tetracycline</span>
 
             <span>Figure 1. Biomass Concentration curve of Pus323-tke4-ike4 Strain with tetracycline</span>
 
         </div>
 
         </div>
Line 143: Line 165:
 
             effective. The results also proved that adding tetracycline to strain will boost the growth of strain. It
 
             effective. The results also proved that adding tetracycline to strain will boost the growth of strain. It
 
             determines that the optimal concentration of tetracycline is 300µg/L to 500µg/L.</div>
 
             determines that the optimal concentration of tetracycline is 300µg/L to 500µg/L.</div>
         <div class="article-title">==Contribution==</div>
+
         <div class="article-title">BBa_K4028006</div>
 +
        <div class="article-content"><b>== Profile ==</b></div>
 +
        <div class="article-content">
 +
            Name: tet pro-ike2<br />
 +
            Base Pairs: 533 bp<br />
 +
            Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic<br />
 +
            Properties: Gene technology for protecting patented bacterial strains
 +
        </div>
 +
        <div class="article-content"><b>== Usage and Biology ==</b></div>
 +
        <div class="article-content">A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs,
 +
            including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit
 +
            the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6]
 +
            Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or
 +
            antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical
 +
            contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate
 +
            and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
 +
        </div>
 +
        <div class="article-content"><b>== Construct design ==</b></div>
 +
        <div class="article-content">The immunity effector ike2 is under tet promoter. The composite part is inserted in
 +
            the pUS232 vector (Figure 3).</div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/5/54/T--Shanghai_Metro--contribution04.jpg" alt="">
 +
            <span>Figure 2. Immune protein expression box.</span>
 +
        </div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/c/c9/T--Shanghai_Metro--contribution05.jpg" alt="">
 +
            <span>Figure 3. Schematic map of immune expression plasmids.</span>
 +
        </div>
 +
        <div class="article-title">BBa_K4028007</div>
 +
        <div class="article-content"><b>== Profile ==</b></div>
 +
        <div class="article-content">
 +
            Name: tet pro-ike4<br />
 +
            Base Pairs: 560 bp<br />
 +
            Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic<br />
 +
            Properties: Gene technology for protecting patented bacterial strains
 +
        </div>
 +
        <div class="article-content"><b>== Usage and Biology ==</b></div>
 +
        <div class="article-content">A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs,
 +
            including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit
 +
            the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6]
 +
            Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or
 +
            antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical
 +
            contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate
 +
            and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
 +
        </div>
 +
        <div class="article-content"><b>== Construct design ==</b></div>
 +
        <div class="article-content">The immunity effector ike4 is under tet promoter(Figure 2). This composite part is
 +
            inserted in the pUS232 vector (Figure 3).</div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/b/b9/T--Shanghai_Metro--contribution06.jpg" alt="">
 +
            <span>Figure 2. Immune protein expression box.</span>
 +
        </div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/b/bc/T--Shanghai_Metro--contribution07.jpg" alt="">
 +
            <span>Figure 3. Schematic map of immune expression plasmids.</span>
 +
        </div>
 +
        <div class="article-title">BBa_K4028008</div>
 +
        <div class="article-content"><b>== Profile ==</b></div>
 +
        <div class="article-content">
 +
            Name: lac pro-tke2-tet pro-ike2<br />
 +
            Base Pairs: 4746 bp<br />
 +
            Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic<br />
 +
            Properties: Gene technology for protecting patented bacterial strains
 +
        </div>
 +
        <div class="article-content"><b>== Usage and Biology ==</b></div>
 +
        <div class="article-content">A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs,
 +
            including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit
 +
            the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6]
 +
            Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or
 +
            antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical
 +
            contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate
 +
            and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
 +
        </div>
 +
        <div class="article-content"><b>== Construct design ==</b></div>
 
         <div class="article-content">With this idea coming from the T6SS, we designed to express the effector components
 
         <div class="article-content">With this idea coming from the T6SS, we designed to express the effector components
 
             of T6SS in industrial strains by inserting the gene segment tke2-ike2 to induce the controlled expression of
 
             of T6SS in industrial strains by inserting the gene segment tke2-ike2 to induce the controlled expression of
Line 150: Line 245:
 
             experiment. </div>
 
             experiment. </div>
 
         <div class="img-wrap">
 
         <div class="img-wrap">
             <img src="https://static.igem.org/mediawiki/2021/6/67/T--Shanghai_Metro--contribution04.png" alt="">
+
             <img src="https://static.igem.org/mediawiki/2021/7/7a/T--Shanghai_Metro--contribution08.jpg" alt="">
             <span>Figure1. The gene design of TetR promoter-ike2-lac promoter-tke2.</span>
+
             <span>Figure2. The gene design of TetR promoter-ike2-lac promoter-tke2.</span>
 +
        </div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/2/27/T--Shanghai_Metro--contribution09.jpg" alt="">
 +
            <span>Figure 3. Schematic map of T6SS effector and immune expression plasmids.</span>
 +
        </div>
 +
        <div class="article-title">BBa_K4028009</div>
 +
        <div class="article-content"><b>== Profile ==</b></div>
 +
        <div class="article-content">
 +
            Name: lac pro-tke4-tet pro-ike4<br />
 +
            Base Pairs: 5208 bp<br />
 +
            Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic<br />
 +
            Properties: Gene technology for protecting patented bacterial strains
 +
        </div>
 +
        <div class="article-content"><b>== Usage and Biology ==</b></div>
 +
        <div class="article-content">A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs,
 +
            including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit
 +
            the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6]
 +
            Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or
 +
            antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical
 +
            contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate
 +
            and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
 +
        </div>
 +
        <div class="article-content"><b>== Construct design ==</b></div>
 +
        <div class="article-content">Tke4 is a key functional factor that inhibits bacterial growth which is controlled
 +
            by a lac promoter (Figure 2). The immunity effector ike4 is under tet promoter. The anti-bacterial effector
 +
            tke4 and the immunity effector ike4 are inserted in the pUS232 vector (Figure 3).</div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/6/63/T--Shanghai_Metro--contribution10.jpg" alt="">
 +
            <span>Figure 2. T6SS effector and immune protein expression box.</span>
 +
        </div>
 +
        <div class="img-wrap">
 +
            <img src="https://static.igem.org/mediawiki/2021/a/ad/T--Shanghai_Metro--contribution11.jpg" alt="">
 +
            <span>Figure 3. Schematic map of T6SS effector and immune expression plasmids.</span>
 
         </div>
 
         </div>
 
     </div>
 
     </div>

Latest revision as of 02:43, 20 October 2021

Shanghai_Metro

Parts Contribution
BBa_K4028000
== Profile ==
Name: tke2
Base Pairs: 4158 bp
Origin: Pseudomonas putida KT2440, genome
Properties: Anti-bacterial effector in type VI secretion system
== Usage and Biology ==
BBa_K4028000 is a coding sequence of tke2 from Pseudomonas putida KT2440. Tke2, known as a toxic Rhs-type effector, is an effect factor in type VI secretion system (T6SS). A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting the growth of recipient cells. The bacteria encoding T6SS can translate and produce corresponding immune proteins to counteract the damage caused by toxic effector factors.[1,2,3]
Figure1. Principle diagram of T6SS.
BBa_K4028001
== Profile ==
Name: ike2
Base Pairs: 447bp
Origin: Pseudomonas putida KT2440, genome
Properties: Immunity effector in type VI secretion system
== Usage and Biology ==
BBa_K4028001 is a coding sequence of ike2, an immunity protein in Pseudomonas putida KT2440. Ike2 is used for protecting bacteria from type VI secretion system (T6SS).
A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate and produce corresponding immune protein (ike2) to counteract the damage caused by toxic effector factors.[1,2,3]
BBa_K4028005
== Profile ==
Name: tet promoter
Base Pairs: 56bp
Origin: Escherichia coli, synthetic
Properties: Inducible promoter regulated by tetracycline
== Usage and Biology ==
This is the naturally-occuring version of the TetR class B promoter. Note that this will promote bidirectionally. (pR1 and pR2 will promote in the forward direction; pA will promote in the reverse direction.) The three transcription start sites are not labeled, but can be found from the reference.
We set different tetracycline concentrations to test the protein expression induced by TetR(B) promoter. In our design, the immune protein (ike4) is regulated by TetR(B) promoter. The expression of the immune protein (ike4) directly affects and is positively correlated with strain growth. Therefore, the strain growth can indicate the regulation of the TetR(B) promoter.
The results of the test are below.
Table 1. OD600 value of the strain D: Pus232-ike4-tke4 after 6 hours
Figure 1. Biomass Concentration curve of Pus323-tke4-ike4 Strain with tetracycline
The results show that concentrations at the range of 300-500µg/L are more effective. The results also proved that adding tetracycline to strain will boost the growth of strain. It determines that the optimal concentration of tetracycline is 300µg/L to 500µg/L.
BBa_K4028006
== Profile ==
Name: tet pro-ike2
Base Pairs: 533 bp
Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic
Properties: Gene technology for protecting patented bacterial strains
== Usage and Biology ==
A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
== Construct design ==
The immunity effector ike2 is under tet promoter. The composite part is inserted in the pUS232 vector (Figure 3).
Figure 2. Immune protein expression box.
Figure 3. Schematic map of immune expression plasmids.
BBa_K4028007
== Profile ==
Name: tet pro-ike4
Base Pairs: 560 bp
Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic
Properties: Gene technology for protecting patented bacterial strains
== Usage and Biology ==
A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
== Construct design ==
The immunity effector ike4 is under tet promoter(Figure 2). This composite part is inserted in the pUS232 vector (Figure 3).
Figure 2. Immune protein expression box.
Figure 3. Schematic map of immune expression plasmids.
BBa_K4028008
== Profile ==
Name: lac pro-tke2-tet pro-ike2
Base Pairs: 4746 bp
Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic
Properties: Gene technology for protecting patented bacterial strains
== Usage and Biology ==
A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
== Construct design ==
With this idea coming from the T6SS, we designed to express the effector components of T6SS in industrial strains by inserting the gene segment tke2-ike2 to induce the controlled expression of the corresponding immune proteins. The normal growth of industrial microorganisms can be ensured only by adding certain components (tetracycline) in the fermentation broth, so as to achieve the purpose of the experiment.
Figure2. The gene design of TetR promoter-ike2-lac promoter-tke2.
Figure 3. Schematic map of T6SS effector and immune expression plasmids.
BBa_K4028009
== Profile ==
Name: lac pro-tke4-tet pro-ike4
Base Pairs: 5208 bp
Origin: Escherichia coli, Pseudomonas putida KT2440, synthetic
Properties: Gene technology for protecting patented bacterial strains
== Usage and Biology ==
A wide range of Gram-negative bacteria have been shown to have antibacterial T6SSs, including opportunistic pathogens such as Pseudomonas aeruginosa,[4] obligate commensal species that inhabit the human gut (Bacteroides spp.),[5] and plant-associated bacteria such as Agrobacterium tumefaciens.[6] Under natural conditions, bacterial cells encoding T6SS transport effect factors with cytotoxic or antibacterial effects (amidase, glycoside hydrolyase, lipase, etc.) to recipient cells through physical contact, thus inhibiting the growth of recipient cells. Meanwhile, the bacteria encoding T6SS can translate and produce corresponding immune protein to counteract the damage caused by toxic effector factors.[1,2,3]
== Construct design ==
Tke4 is a key functional factor that inhibits bacterial growth which is controlled by a lac promoter (Figure 2). The immunity effector ike4 is under tet promoter. The anti-bacterial effector tke4 and the immunity effector ike4 are inserted in the pUS232 vector (Figure 3).
Figure 2. T6SS effector and immune protein expression box.
Figure 3. Schematic map of T6SS effector and immune expression plasmids.